RobertE.GoldsbyMD

Pediatric Hematology & Oncology • San Francisco, CA

Professor of Clinical Pediatrics, UCSF School of Medicine

Join to view full profile

Dr. Goldsby is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Goldsby's full profile

Already have an account?

Office
550 16th St
# 434
San Francisco, CA 94143
Phone+1 415-476-3831

Fax+1 415-502-4372

Summary

Dr. Robert Goldsby, located in San Francisco, specializes in Pediatric Hematology and Oncology. He completed his Residency in Pediatrics at Children's Hospital-Oakland and a Fellowship in Pediatric Hematology/Oncology at the University of Utah Health. Currently a Professor at UCSF Medical Center, he also actively contributes to the medical field with numerous publications. His works have been recognized and cited multiple times by fellow researchers. Dr. Goldsby additionally participates in several clinical trials, including the treatment strategies for osteosarcoma, lymphomas, and liver cancer in young patients, showcasing his active role in advancing treatment for childhood cancers.

Education & Training

University of Utah HealthFellowship, Pediatric Hematology/Oncology, 1994 - 1997
Children's Hospital-OaklandResidency, Pediatrics, 1991 - 1994
University of Vermont College of MedicineClass of 1991

Certifications & Licensure

CA State Medical License 2002 - 2025
UT State Medical License 1994 - 2004
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma Start of enrollment: 2001 Oct 18
Active, not recruiting
Phase 3
131 I-MIBG in Treating Patients With Refractory or Relapsed Neuroblastoma Start of enrollment: 2005 Apr 01
Completed
Phase 2
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies Start of enrollment: 2008 Jul 17
Recruiting
Zoledronic Acid and Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma Start of enrollment: 2008 Aug 01
Completed
Phase 1
Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer Start of enrollment: 2003 Oct 13
Completed
Study of Kidney Tumors in Younger Patients Start of enrollment: 2006 Feb 27
Recruiting
Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma Start of enrollment: 1999 Mar 15
Completed
Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor Start of enrollment: 2009 Jul 13
Active, not recruiting
Phase 3
Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer Start of enrollment: 2009 Sep 14
Active, not recruiting
Phase 3
Childhood Cancer Survivor Study Start of enrollment: 1995 Jan 05
Recruiting
Blood Sample Markers of Reproductive Hormones in Assessing Ovarian Reserve in Younger Patients With Newly Diagnosed Lymphomas Start of enrollment: 2013 Jun 17
Active, not recruiting
Eribulin Mesylate in Treating Patients With Recurrent or Refractory Osteosarcoma Start of enrollment: 2014 Aug 01
Completed
Phase 2
Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer Start of enrollment: 2009 Sep 01
Join now to see all

Publications & Presentations

PubMed

180 citations
DNA polymerase ε and δ proofreading suppress discrete mutator and cancer phenotypes in mice
Tina M. Albertson, Masanori Ogawa, James M. Bugni, Laura E. Hays, Yang Chen
Proceedings of the National Academy of Sciences of the United States of America. 2009-10-06
86 citations
Mutation at the Polymerase Active Site of Mouse DNA Polymerase δ Increases Genomic Instability and Accelerates Tumorigenesis
Ranga N. Venkatesan, Piper M. Treuting, Evan D. Fuller, Robert E. Goldsby, Thomas H. Norwood
Molecular and Cellular Biology. 2007-11-01
209 citations
Fibrodysplasia ossificans progressiva
Frederick S. Kaplan, Martine Le Merrer, David L. Glaser, Robert J. Pignolo, Robert E. Goldsby
Best Practice & Research. Clinical Rheumatology. 2008-03-01

Press Mentions

Special Notice Concerning COVID-19February 9th, 2021
Researchers, Physicians Caution Against Use of Solitary Confinement to Prevent COVID-19 Spread in PrisonsJuly 14th, 2020
Childhood Cancer Burden Much Bigger Than Previously RecognizedJuly 28th, 2019
Join now to see all